enGene Therapeutics Inc (ENGN) insider trading
Every open-market stock purchase and sale by enGene Therapeutics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Forbion Growth Opportunities Fund I Cooperatief U.A. (Insider), $5M, 23 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent ENGN insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 16, 2026 | William Grossman (C-suite exec) | Bought (not open market) | — |
| Jun 16, 2026 | Wouter Joustra (Insider) | Bought (not open market) | — |
| Jun 16, 2026 | Michael Thomas Heffernan (Insider) | Bought (not open market) | — |
| Jun 16, 2026 | Paul J Hastings (Insider) | Bought (not open market) | — |
| Jun 16, 2026 | William Grossman (C-suite exec) | Bought (not open market) | — |
| Jun 16, 2026 | Gerald A Brunk (Insider) | Bought (not open market) | — |
| Jun 16, 2026 | Richard M Glickman (Insider) | Bought (not open market) | — |
| Jun 16, 2026 | Lota S. Zoth (Insider) | Bought (not open market) | — |
| Jun 16, 2026 | Philip Astley-Sparke (Insider) | Bought (not open market) | — |
| Jan 30, 2026 | D. Ryan Daws (CFO) | Bought (not open market) | — |
| Jan 30, 2026 | Joan Connolly (CTO) | Bought (not open market) | — |
| Jan 30, 2026 | Matthew Ross Boyd (C-suite exec) | Bought (not open market) | — |
| Jan 30, 2026 | Anthony Tzeyew Cheung (C-suite exec) | Bought (not open market) | — |
| Jan 30, 2026 | Alexander Julian Nichols (Officer) | Bought (not open market) | — |
| Jan 30, 2026 | Lee Giguere (Officer) | Bought (not open market) | — |
| Jan 30, 2026 | Jill Buck (C-suite exec) | Bought (not open market) | — |
| Jan 30, 2026 | Ronald Harold Wilfred Cooper (CEO) | Bought (not open market) | — |
Who's trading ENGN
- Philip Astley-Sparke, Insider: other filings, last Jun 16, 2026
- Gerald A Brunk, Insider: other filings, last Jun 16, 2026
- Richard M Glickman, Insider: other filings, last Jun 16, 2026
- William Grossman, C-suite exec: other filings, last Jun 16, 2026
- Paul J Hastings, Insider: other filings, last Jun 16, 2026
- Michael Thomas Heffernan, Insider: other filings, last Jun 16, 2026
- Wouter Joustra, Insider: other filings, last Jun 16, 2026
- Lota S. Zoth, Insider: other filings, last Jun 16, 2026
- Ronald Harold Wilfred Cooper, CEO: other filings, last Jan 30, 2026
- D. Ryan Daws, CFO: other filings, last Jan 30, 2026
- Lee Giguere, Officer: other filings, last Jan 30, 2026
- Alexander Julian Nichols, Officer: other filings, last Jan 30, 2026
- Matthew Ross Boyd, C-suite exec: other filings, last Jan 30, 2026
- Jill Buck, C-suite exec: other filings, last Jan 30, 2026
- Anthony Tzeyew Cheung, C-suite exec: other filings, last Jan 30, 2026
Get free alerts when an insider at enGene Therapeutics Inc files a new trade →